McBride William T, Kurth Mary Jo, Watt Joanne, Irvine Allister, Domanska Anna, McLean Gavin, Lamont John V, Fitzgerald Peter, Ruddock Mark W
Department of Cardiac Anaesthesia, Belfast Health & Social Care Trust, Belfast, United Kingdom.
Clinical Studies Group, Randox Laboratories Ltd, Crumlin, United Kingdom.
Front Endocrinol (Lausanne). 2024 Dec 26;15:1441632. doi: 10.3389/fendo.2024.1441632. eCollection 2024.
In patients undergoing orthopaedic trauma surgery, acute kidney injury (AKI) can develop post-operatively and is a major cause of increased mortality and hospital stay time. Development of AKI is associated with three main processes: inflammation, ischaemia-reperfusion injury (IRI) and hypoperfusion. In this study, we investigated whether ratios of urine and blood anti-inflammatory biomarkers and biomarkers of hypoperfusion, IRI and inflammation are elevated in patients who develop post-trauma orthopaedic surgery acute kidney injury (PTOS-AKI).
Blood and urinary biomarkers of inflammation, hypoperfusion and IRI were analysed in 237 patients undergoing orthopaedic fracture surgery pre- and post-operatively. Biomarker ratios were compared between non-PTOS-AKI and PTOS-AKI patients.
Multiple inflammatory biomarkers were significantly elevated in PTOS-AKI patients compared to non-PTOS-AKI patients. When urine anti-inflammatory biomarkers were expressed as biomarker ratios with biomarkers of inflammation, hypoperfusion and IRI, multiple ratios were lower in PTOS-AKI patients. In contrast, blood anti-inflammatory biomarkers when expressed as ratios with blood proinflammatory biomarkers were elevated in PTOS-AKI patients.
Reductions in ratios of urine anti-inflammatory and proinflammatory biomarkers in PTOS-AKI patients suggest that the renal anti-inflammatory response is protective against the proinflammatory response in patients who do not develop PTOS-AKI. Detection of proinflammatory and anti-inflammatory biomarkers both pre- and post-operatively may be useful in detecting patients at risk of developing AKI after orthopaedic surgery.
在接受骨科创伤手术的患者中,急性肾损伤(AKI)可在术后发生,是死亡率增加和住院时间延长的主要原因。AKI的发生与三个主要过程相关:炎症、缺血再灌注损伤(IRI)和低灌注。在本研究中,我们调查了发生创伤后骨科手术急性肾损伤(PTOS-AKI)的患者尿液和血液中的抗炎生物标志物以及低灌注、IRI和炎症生物标志物的比值是否升高。
对237例接受骨科骨折手术的患者术前和术后的血液及尿液中的炎症、低灌注和IRI生物标志物进行分析。比较非PTOS-AKI患者和PTOS-AKI患者的生物标志物比值。
与非PTOS-AKI患者相比,PTOS-AKI患者的多种炎症生物标志物显著升高。当尿液抗炎生物标志物与炎症、低灌注和IRI生物标志物以生物标志物比值表示时,PTOS-AKI患者的多种比值较低。相反,当血液抗炎生物标志物与血液促炎生物标志物以比值表示时,PTOS-AKI患者的该比值升高。
PTOS-AKI患者尿液抗炎和促炎生物标志物比值降低表明,在未发生PTOS-AKI的患者中,肾脏抗炎反应可对抗促炎反应。术前和术后检测促炎和抗炎生物标志物可能有助于检测骨科手术后有发生AKI风险的患者。